HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells

被引：0
|
作者：
J. R. Ribeiro
C. Schorl
N. Yano
N. Romano
K. K. Kim
R. K. Singh
R. G. Moore
机构：
[1] Women and Infants Hospital,Center for Genomics and Proteomics, Genomics Core Facility
[2] Department of Obstetrics and Gynecology,Wilmot Cancer Institute, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology
[3] Program in Women’s Oncology,undefined
[4] Molecular Therapeutics Laboratory,undefined
[5] Brown University,undefined
[6] University of Rochester Medical Center,undefined
来源：
Journal of Ovarian Research | / 9卷
关键词：
HE4; Epithelial ovarian cancer; Chemoresistance; Paclitaxel resistance; Platinum resistance; MAPK signaling; Tubulin; EGR1; SKOV3 cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
    Cheryl A Sherman-Baust
    Kevin G Becker
    William H Wood III
    Yongqing Zhang
    Patrice J Morin
    Journal of Ovarian Research, 4
  • [32] Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
    Sherman-Baust, Cheryl A.
    Becker, Kevin G.
    Wood, William H.
    Zhang, Yongqing
    Morin, Patrice J.
    JOURNAL OF OVARIAN RESEARCH, 2011, 4
  • [33] Decreased Expression of Enolase-I Promotes Cisplatin Resistance of Ovarian Cancer Cells
    Rabelo-Fernandez, Robert Joe
    Vivas-Mejia, Pablo
    Santana-Rivera, Yasmarie
    FASEB JOURNAL, 2019, 33
  • [34] BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells
    Chock, Kerri L.
    Allison, Jamie M. S.
    Shimizu, Yoshiko
    ElShamy, Wael M.
    CANCER RESEARCH, 2010, 70 (21) : 8782 - 8791
  • [35] DCLK1 Promotes Cisplatin Resistance in Ovarian Cancer
    Dogra, Samrita
    Moxley, Katherine
    Hannafon, Bethany N.
    AMERICAN JOURNAL OF PATHOLOGY, 2021, 191 (10 S): : S1 - S1
  • [36] The Human epididymis protein 4 (HE4) as a marker of ovarian cancer recurrence
    Michienzi, Simona
    Falzarano, Renato
    Viggiani, Valentina
    Rossini, Daniele
    Longo, Flavia
    Anastasi, Emanuela
    BIOCHIMICA CLINICA, 2013, 37 (03) : 195 - 199
  • [37] Intraperitoneal cisplatin and paclitaxel in ovarian cancer
    Armstrong, DK
    Bundy, B
    Wenzel, L
    Huang, HQ
    Baergen, R
    Lele, S
    Copeland, LJ
    Walker, JL
    Burger, RA
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01): : 34 - 43
  • [38] Intraperitoneal cisplatin and paclitaxel in ovarian cancer
    Hariprasad, Roopa
    Kumar, Lalit
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2006, 27 (03) : 35 - 38
  • [39] Diagnostic value of HE4 for ovarian cancer: a meta-analysis
    Yu, Shuang
    Yang, Hui-jie
    Xie, Shu-qin
    Bao, Yi-Xi
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (08) : 1439 - 1446
  • [40] HE4: a new potential early biomarker for the recurrence of ovarian cancer
    Anastasi, Emanuela
    Marchei, Giulia Giovanna
    Viggiani, Valentina
    Gennarini, Giuseppina
    Frati, Luigi
    Reale, Maria Gabriella
    TUMOR BIOLOGY, 2010, 31 (02) : 113 - 119
12345